Arcus Biosciences (RCUS) Accumulated Depreciation & Amortization: 2017-2024
Historic Accumulated Depreciation & Amortization for Arcus Biosciences (RCUS) over the last 3 years, with Dec 2024 value amounting to $41.0 million.
- Arcus Biosciences' Accumulated Depreciation & Amortization rose 32.26% to $41.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $113.0 million, marking a year-over-year increase of 30.96%. This contributed to the annual value of $10.0 million for FY2024, which is 25.00% up from last year.
- As of Q4 2024, Arcus Biosciences' Accumulated Depreciation & Amortization stood at $41.0 million, which was up 32.26% from $31.0 million recorded in Q4 2023.
- In the past 5 years, Arcus Biosciences' Accumulated Depreciation & Amortization registered a high of $41.0 million during Q4 2024, and its lowest value of $14.3 million during Q4 2020.
- Its 3-year average for Accumulated Depreciation & Amortization is $31.7 million, with a median of $31.0 million in 2023.
- Data for Arcus Biosciences' Accumulated Depreciation & Amortization shows a peak YoY soared of 34.78% (in 2023) over the last 5 years.
- Arcus Biosciences' Accumulated Depreciation & Amortization (Quarterly) stood at $14.3 million in 2020, then climbed by 25.98% to $18.0 million in 2021, then climbed by 27.78% to $23.0 million in 2022, then spiked by 34.78% to $31.0 million in 2023, then spiked by 32.26% to $41.0 million in 2024.
- Its last three reported values are $41.0 million in Q4 2024, $31.0 million for Q4 2023, and $23.0 million during Q4 2022.